Breathe Well Live Well
|
Olympic Games / Drug suspicions / Traces of banned substance found in marathon …
Haaretz The Olympic Committee of Israel revealed yesterday that traces of a substance normally found in inhalers for asthma sufferers were detected, but the OCI will wait until the results of a second test bottle arrive on Friday. Olympics: Israeli Olympian Zemiro fails drug test |
View full post on asthma – Google News
|
Chain to cut drug prices by average of 25%
Irish Times This will save people on medications for conditions including asthma and heart disease up to €300 a year. The savings are the result of a dramatic overhaul of the Boots Ireland pricing model. It has abandoned the traditional 50 per cent mark-up that … Cost of prescription medicines to fall Boots to cut medicine prices from Friday Boots to cut cost of prescription medicines for customers in Ireland |
View full post on asthma – Google News
|
MediciNova shares plunge as asthma drug fails in Ph IIb trial
The Pharma Letter MediciNova intends to design pivotal trial(s) that will include technological and operational improvements and further controls for medications that are not typically used in the treatment of acute exacerbations of asthma and were over-represented in … |
View full post on asthma – Google News
|
MediciNova shares crash after lead asthma drug fails IIb trial
FierceBiotech MediciNova's ($MNOV) shares crashed after the San Diego-based biotech said its Phase IIb study of an acute asthma drug failed to hit the primary endpoint. And while the CEO tried to put the data in context, offering reasons for optimism for a planned … MediciNova asthma drug fails trial; shares crash MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma … |
View full post on asthma – Google News
|
MediciNova asthma drug fails trial; shares crash
Reuters (Reuters) – Biopharmaceutical company MediciNova Inc said its experimental asthma drug failed to meet the main goal of a second mid-stage trial, sending its shares down as much as 51 percent in extended trade. MediciNova, which is testing MN-221 as a … MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma … MediciNova (MNOV) Says Results of Phase 2B Trial of MN-221 Didn't Meet Primary … |
View full post on asthma – Google News
|
Asthma drug discovery
Medical Xpress (Medical Xpress) — Researchers from King's College London have uncovered a new mechanism of action for a group of asthma drugs already on the market, which could enable more effective treatment for patients with a particular type of allergic asthma … |
View full post on asthma – Google News
|
Biopharma raising $500K eyes competitive asthma/COPD drug market
MedCity News A biopharmaceutical startup developing a new treatment for asthma that targets the nitric oxide signaling system has raised $50000 of a planned $500000 fundraise, according to recently filed SEC documents. SAJE Pharma LLC's lead compound appears to … |
View full post on asthma – Google News
|
Asthma drug discovery
HealthCanal.com Researchers from King's College London have uncovered a new mechanism of action for a group of asthma drugs already on the market, which could enable more effective treatment for patients with a particular type of allergic asthma – between 30 to 50 per … |
View full post on asthma – Google News
|
Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute …
Sacramento Bee One of these agents, R343, an inhaled SYK inhibitor, will be entering a Phase 2 clinical study later this summer in mild to moderate asthmatic patients. The other, R256, an inhaled IL13 signaling/JAK inhibitor, is potentially useful in controlling … Rigel moving asthma drug into mid-stage trial |
View full post on asthma – Google News
|
Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute …
MarketWatch (press release) SOUTH SAN FRANCISCO, Calif., May 16, 2012 /PRNewswire via COMTEX/ — Rigel Pharmaceuticals, Inc., (NASDAQ:RIGL) is expanding its respiratory franchise by focusing on two innovative, comprehensive treatment alternatives for patients with asthma. |
View full post on asthma – Google News